translated from Spanish: Vaccine to be tested in Chile passes the test against all covid strains

They are optimistic that they see in China the new results obtained from the vaccine that sinovac is preparing, one of the most advanced developments against Covid-19 in the world and which has been the first with which Chile agreed to try it with the local population.
The firm’s delegate, Yin Weidong, said yesterday that as part of the phase 3 clinical studies that began in late July to date have already tested the vaccine on 20 different strains of Sars-CoV-2, achieving satisfactory results in all of them, including samples from the United States, Europe, Middle Eastern countries and China itself , where the pandemic is presumed to have originated.
“Our vaccine can neutralize all strains of the virus globally, and we predict it will have a protective effect on the world,” Yin said in an interview with CGTN state television.
The official realized that after applying two doses of its development, between 97 and 98 percent of the inoculated generated antibodies.
Sinovac has prepared to produce 300 million doses a year, for which they built a 20 thousand square meter factory in three months. They have promised “broad” access to the world’s population once they complete the tests.
His degree of progress led to the Signing of an agreement with the institution in June, which was then supported by the Government and seven other study houses to test three thousand humans of the vaccine in Chile, to ensure priority access to doses when ready.
Last week UC Rector Ignacio Sánchez told Radio Pauta that they are waiting for the Institute of Public Health (ISP) to evaluate their proposal to import the vaccine. When they get the go-ahead, estimate that in a week the doses would arrive, and in a maximum of two weeks they would start the call for volunteers.
But it would not be the only good outcome for the inoculation of the week, as cases of reinfection of the virus in at least three patients recovered from China, Belgium and the Netherlands have increased the confidence of some experts about the effectiveness of the future vaccine.
One of the optimists is Miguel O’Ryan, a member of the government’s vaccine advisory team. The expert commented on Cooperative radio that the recasts have had a second asymptomatic infection or with mild symptoms, which would confirm that the presence of Sars-CoV-2 in the body would create a high immune protection, the same one that is expected to replicate with vaccines that insert the deactivated virus into the body.
“It’s promising. The goal of the vaccine is to try to emulate the immune response left by a natural infection without producing the disease,” he explained.
At the day, the Pan American Health Organization warned that coronavirus deaths and cases have doubled in recent weeks on the continent, and expressed concern about the “disproportionate” incidence of the virus on the young population, who, they say, would be the “main drivers of the spread” in the region.
Chile yesterday reported 1,406 new and 42-dead contagions, reaching 400,985 total infected and 10,958 deaths.
158,000 children on the street
Carabineros reported that they granted 158,513 permits for children to take to the streets in quarantined areas during the first week of the document.” The most used day to leave was Friday, and 89% of requests were for the afternoon time.



Original source in Spanish

Related Posts

Add Comment